Harm Westdorp

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp et al. · Clinical Cancer Research · 2015 · 231 citations

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas et al. · Cancer Immunology Immunotherapy · 2020 · 58 citations · Full text

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Kalijn F. Bol, Thomas van den Bosch, Gerty Schreibelt et al. · Ophthalmology · 2016 · 47 citations · Full text

Vaccination, Melanoma, Immunology +4

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Steve Boudewijns, Harm Westdorp, Rutger H.T. Koornstra et al. · Journal of Immunotherapy · 2016 · 32 citations · Full text

Dendritic Cell, Immunology, Pathology +19